News Headlines Article

AthenaHealth buys Epocrates for $293 million
San Francisco Business Times

AthenaHealth Inc. has agreed to acquire Epocrates Inc. for about $293 million to gain the company’s mobile health care technology. AthenaHealth (NASDAQ: ATHN) agreed to pay $11.75 per share in cash for Epocrates (NASDAQ: EPOC), which represents a 22 percent premium over Epocrates’s closing price Friday. AthenaHealth said it would finance the acquisition with available cash and an existing credit facility.